Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: An in situ hybridization study

Journal of Neuroendocrinology

Volumn 15, Issue 6, 2003, Pages 586-591

  Laorden, M L ^a   Milanes M V ^a   Angel, E ^b   Tankosic, P ^b   Burlet, A ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b INSERM   (France)

Author keywords

AVP mRNA; Corticosterone; CRF mRNA; Hypothalamic paraventricular nucleus (PVN); In situ hybridization; Morphine; Noradrenergic activity

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; MORPHINE;

ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; GENE EXPRESSION; HORMONE SYNTHESIS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0038280107     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2003.01037.x     Document Type: Article

References (31)

1. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin releasing factor. Pharmacol Rev 1991; 43: 425-473.
2. Cunningham ET, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1988; 274: 60-76.
3. Itoi K, Seasholtz AF, Watson SJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocrine J 1998; 45: 13-33.
4. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 1994; 135: 2177-2182.
5. Renaud LP, Bourque CW. Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxitocyn. Prog Neurobiol 1991; 36: 131-169.
6. Itoi K, Helmreich DL, Lopez-Figueroa MO, Watson SJ. Diferential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 1999; 19: 5464-5472.
7. Suemaru S, Dallman MF, Drlington DN, Cascio CS, Shisako J. Role of alpha adrenergic mechanisms in effects of morphine on the hypothalamus-pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendocrinology 1989; 49: 181-190.
8. 2+ channel ligands modulate morphine effects on the hypothalamus-pituitary-adrenocortical axis in rat. Eur J Pharmacol 1993; 232: 191-198.
9. Gonzálvez ML, Milanés MV, Martínez-Piero MG, Marín MT, Vargas ML. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naïve rats and after naloxone-induced withdrawal. Brain Res 1994; 647: 199-203.
10. Vargas ML, Martínez-Piñero MG, Milanés MV. Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: the role of calcium channels. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 355: 501-506.
11. Fuertes G, Milanés MV, Rodríguez-Gago M, Marín MT, Laorden ML. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration. Eur J Pharmacol 2000; 388: 49-56.
12. Milanés MV, Laorden ML, Chapleur-Château M, Burlet A. Differential regulation of cortotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations wiehr hypothalamic noradrenergic activity and pituitary-adrenal response. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 356: 603-610.
13. Berhow MT, Russel DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, Nestler EJ. Influence of neurotrophic factors on morphine-and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 1995; 68: 969-979.
14. Walker CD, Tankosic P, Tilders FJH, Burlet A. Innunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance. J Neuroendocrinol 1997; 3: 469-475.
15. Sherman TG, McKelvy JF, Watson SJ. Vasopressing mRNA regulation in individual hypothalamic muclei: northen and in situ hybridization analysis. J Neuroimmunol 1986; 6: 1685-1694.
16. Jingami H, Mizuno N, Takahashi H, Shibahara S, Furutani Y, Imura H, Numa S. Cloning and sequence analysis of cDNA for rat corticotropin-releasing factor prexursor. FEBS Lett 1985; 191: 63-68.
17. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 1973; 59: 449-450.
18. Palkovits M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. New York: Elsevier, 1988.
19. Artigas F, Sarrias MJ, Adell A, Gelpí E. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sci 1986; 39: 1571-1578.
20. Tsagarakis S, Navara P, rees LH, Besser M, Grossman A. Morphine directly modulates the release of stimulated corticotropin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology 1989; 124: 2330-2335.
21. Wang XQ, Imaki T, Shibasaki T, Yamauchi N, Demura H. Intracerebroventricular administration of β-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat. Brain Res 1996; 707: 189-195.
22. Kovács K, Sawchenko PE. Sequence of stress-induced alteration in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 1996; 16: 262-273.
23. Dent GV, Smith MA, Levine S. Rapid induction of corticotropin-releasing hormone gene transcription in the paraventricular nuecleus of the developing rat. Endrocrinology 2000; 141: 1593-1598.
24. Pinnock SB, Herbert J. Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. Eur J Neurosci 2001; 13: 576-584.
25. Kovács K. c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 1998; 33: 287-297.
26. Kovács KJ, Arias C, Sawchenko PE. Protein synthesis blockade differentially affects the stress-induced transcriptional activation of neuorpeptide genes in parvocellular neurosecretory neurons. Mol Brain Res 1998; 54: 85-91.
27. Lightman SL, Young WS. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol 1988; 403: 511-523.
28. Hinz B, Hirschelmann R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharmacol Res 2000; 17: 1273-1277.
29. Walker CD, Tilders FSH, Burlet A. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurons of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry. J Neuroendocrinol 2001; 13: 74-78.
30. Kiss A, Aguilera G. Regulation of hypothalamic pituitary adrenal axis during chronic stress: response to repeated intraperitoneal hypertonic saline injection. Brain Res 1993; 630: 262-270.
31. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Neuroendocrinology 1994; 15: 321-350.